Spinal Muscular Atrophies of Childhood: all 61 studies
Page 1 of 1. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- SPX-01 Gene Therapy in Pediatric Patients With Spinal Muscular Atrophy Type 1 (RISE)Not yet recruitingNCT07903376Early Phase 1
- Exploring Lived Experiences of Families of Children With Spinal Muscular Atrophy(SMA) Type 1 Regarding Feeding and CommunicationNot yet recruitingNCT07596277
- A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type IRecruitingNCT07554924Phase 1/2
- Gait and Bone Health in SMARecruitingNCT07400198
- Psychological Evaluation of the Parental Experience of Newborn Screening for Infantile Spinal Muscular Atrophy in the Grand Est and Nouvelle-Aquitaine RegionsNot yet recruitingNCT07208903
- Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1RecruitingNCT07070999Phase 1/2
- A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular AtrophyRecruitingNCT07047144Phase 2
- Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular DisordersRecruitingNCT06839469
- GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular AtrophyEnrolling by invitationNCT06772402Not applicable
- Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular AtrophyRecruitingNCT06562283Not applicable
- Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 PatientsRecruitingNCT06421831Phase 1/2
- Test of Aquatic Mobility of SMA InfantsRecruitingNCT06152302Not applicable
- Spinal Cord Gray Matter Imaging in Spinal Muscular AtrophyEnrolling by invitationNCT06137612
- Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1Enrolling by invitationNCT05614531Phase 1/2
- The Effect of Aerobic Exercise Training in Patients With Type III Spinal Muscular AtrophyRecruitingNCT05544994Not applicable
- Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe DiseaseRecruitingNCT05272969
- UK SMA Patient RegistryRecruitingNCT04292574
- Paracetamol Study in Patients With Low Muscle MassRecruitingNCT03648658Phase 4
- Spinal Cord Stimulation in Spinal Muscular AtrophyCompletedNCT05430113Not applicableResults posted
- Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)CompletedNCT05089656Phase 3Results posted
- An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular AtrophyCompletedNCT03921528Phase 2Results posted
- Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 CopiesCompletedNCT03837184Phase 3Results posted
- Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3TerminatedNCT03819660Phase 2Results posted
- Whole Body Vibration Therapy in Children With Spinal Muscular AtrophyTerminatedNCT03056144Not applicableResults posted
- Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1CompletedNCT02122952Phase 1Results posted
- CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type ICompletedNCT00661453Phase 1/2Results posted
- Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or IIITerminatedNCT00439569Phase 1/2Results posted
- Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type ITerminatedNCT00439218Phase 1/2Results posted
- Impact of Motor and Oral Motor Function on Quality of Life in Children With SMACompletedNCT06864767
- Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in SpainCompletedNCT06632730
- Clinical Trial to Evaluate the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy Type ICompletedNCT06576388Early Phase 1
- Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper LimbCompletedNCT06300996Not applicable
- A Clinical Study Evaluating the Safety and Efficacy of SKG0201 Injection in Patients With Spinal Muscular Atrophy Type 1Active, not recruitingNCT06191354Not applicable
- Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 PatientsActive, not recruitingNCT05901987Phase 1/2
- The Effect of Spinal Orthosis on the Development of Scoliosis and Chest Deformity in Type I Spinal Muscular AtrophyCompletedNCT05878418Not applicable
- Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation StudyWithdrawnNCT05839145Not applicable
- Body Weight Support Harness System in Spinal Muscular AtrophyCompletedNCT05715749Not applicable
- Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of ApitegromabActive, not recruitingNCT05626855Phase 3
- Longitudinal Data Collection in Pediatric and Adult Patients With Spinal Muscular Atrophy in Latin AmericaActive, not recruitingNCT05475691
- Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular AtrophyCompletedNCT05416034Not applicable
- Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or RisdiplamCompletedNCT05156320Phase 3
- Musculoskeletal Nociceptive Pain in Participants With Neuromuscular DisordersCompletedNCT04907162
- Evaluation of the Exoskeleton ATLAS 2030 as Robot-assisted Physical Therapy to Children With Neuromuscular DiseasesCompletedNCT04837157Not applicable
- Rehabilitative Effect of the Use of a Gait Exoskeleton in Patients With Neuromuscular Disease or Cerebral PalsyCompletedNCT04813601Not applicable
- Characterization of the Clinical-epidemiological Profile of Patients With SMA5q Types II and III: Observational StudyCompletedNCT04404764
- Wearable Technology to Assess Gait Function in SMA and DMDCompletedNCT04193085
- Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioiActive, not recruitingNCT04042025Phase 3
- Spinraza in Adult Spinal Muscular AtrophyActive, not recruitingNCT03709784
- Long-Term Follow-up Study for Patients From AVXS-101-CL-101Active, not recruitingNCT03421977
- Trial Evaluating the Interest of Noninvasive Ventilation in NAVA Mode in Respiratory Decompensations Children With Infantile Spinal Muscular Atrophy Type IICompletedNCT03395795Not applicable
- SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4CompletedNCT02941328Phase 2
- Oxidative Capacity and Exercise Tolerance in Ambulatory SMACompletedNCT02895789
- Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman PatientsStatus unknownNCT02855112Phase 1/2
- Prospective Evaluation of Infants With Spinal Muscular Atrophy:Status unknownNCT02831296
- Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular AtrophyCompletedNCT02391831Not applicable
- Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3CompletedNCT02227823Phase 2
- Palliative Care in Spinal Muscular Atrophy (SMA) 1CompletedNCT01862042Not applicable
- Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.CompletedNCT01302600Phase 2
- A Pilot Study of Biomarkers for Spinal Muscular AtrophyCompletedNCT00756821
- Pilot Study of Growth Hormon to Treat SMA Typ II and IIICompletedNCT00533221Phase 2
- International SMA Patient RegistryCompletedNCT00466349